Since hepcidin-25 serum levels are mainly affected by inflammation and iron reserves in the body [5,6], this finding suggests that proinflammatory mediators probably stimulate hepatic hepcidin-25 secretion during the active IBD phase. This evidence concerns the gene HAMP and inflammatory bowel disease.